Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (76)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- The adrenal gland houses two endocrine systems
- Classifying endogenous Cushing syndrome
- Adrenal hyperplasia has recognizable patterns
- Primary and secondary hyperaldosteronism
- Nonclassic CAH: Partial steroidogenic impairment
- APS-1 links adrenal autoimmunity to central tolerance
- Cortical adenoma versus carcinoma: Overview
- Primary reference and scope
Slide index & full transcript (76 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Adrenal Cortex
Structure, hormone physiology, hyperfunction, insufficiency, and neoplasia
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Map the cortical zones to their predominant steroid hormones.
Explain hormone excess and deficiency through feedback physiology.
Distinguish causes, morphology, and clinical patterns of major cortical disorders.
Interpret adrenal lesions using morphology, hormone activity, and clinical context.
Slide 3 · The adrenal gland houses two endocrine systems
The cortex and medulla differ in developmental origin, organization, and secretory products.
Cortical cells synthesize steroid hormones; Medullary chromaffin cells release catecholamines.
Cortical pathology may cause excess hormone production, hormone failure, or a mass lesion.
The cortex is the focus of this lecture; Medullary neoplasms form a separate topic.
Slide 4 · Normal adrenal cortex: Zonal organization
Capsule
Fibrous covering
Zona glomerulosa
Aldosterone
Zona fasciculata
Predominant cortical volume; Cortisol
Zona reticularis
Androgens; Some glucocorticoids
Medulla
Catecholamines
Schematic orientation from capsular surface toward the adrenal medulla
Slide 5 · Adrenal zones and predominant outputs
Cortical zone
Principal hormones
Key regulatory linkage
Glomerulosa
Mineralocorticoids (aldosterone)
Renin–angiotensin and potassium
Fasciculata
Glucocorticoids (cortisol)
Pituitary corticotropin (ACTH)
Reticularis
Adrenal androgens; some cortisol
Predominantly corticotropin (ACTH)
Slide 6 · Architecture predicts cortical responses to injury
The zona fasciculata is the broadest zone, comprising roughly three quarters of the cortex.
Glomerulosa lies beneath the capsule; Reticularis borders the medulla.
Chronic corticotropin drive produces enlargement of ACTH-responsive cortical compartments.
ACTH suppression preferentially atrophies fasciculata and reticularis while sparing glomerulosa.
Slide 7 · The hypothalamic–pituitary–adrenal axis
Hypothalamic CRH
Pituitary ACTH
Adrenal cortical cortisol
Glucocorticoid output rises in response to corticotropin.
Cortisol feedback suppresses hypothalamic and pituitary stimulation.
Failure or escape at different levels changes both ACTH and adrenal morphology.
Slide 8 · Feedback explains adrenal atrophy and hyperplasia
High exogenous cortisol
Suppressed pituitary ACTH
Bilateral cortical atrophy
Glucocorticoid medication may suppress endogenous ACTH.
Without trophic ACTH, fasciculata and reticularis regress.
Conversely, sustained ACTH excess drives bilateral cortical hyperplasia.
Slide 9 · Three steroid systems: Principal effects
Steroid class
Major physiologic roles
Characteristic excess
Glucocorticoids
Metabolism; immune suppression; stress response
Cushing syndrome
Mineralocorticoids
Renal Na⁺ retention and K⁺ excretion
Hyperaldosteronism
Adrenal androgens
Sex-steroid precursor contribution
Virilizing syndromes
Slide 10 · A useful first division: Function versus lesion
Hyperfunction: Cortisol, aldosterone, or androgen excess dominates the phenotype.
Hypofunction: Cortical hormone deficiency can be primary or secondary.
Structural pathology: Diffuse or nodular hyperplasia, adenoma, carcinoma, hemorrhage, or infiltration.
The appearance of a cortical mass alone does not establish its hormonal functionality.
Slide 11 · Hormone pattern guides the diagnostic question
Dominant abnormality
Clinical cue
Pathologic question
Cortisol excess
Central adiposity, catabolism, hyperglycemia
ACTH dependent or independent?
Aldosterone excess
Hypertension ± hypokalemia
Autonomous adrenal or renin driven?
Androgen excess
Virilization or precocious puberty
CAH or cortical neoplasm?
Cortisol deficiency
Weakness, hypotension, crisis
Primary adrenal or pituitary?
Slide 12 · Cushing syndrome means sustained glucocorticoid excess
Exogenous glucocorticoid administration is the most common overall cause.
Endogenous hypercortisolism arises from ACTH-dependent or ACTH-independent mechanisms.
Cushing disease specifically denotes pituitary ACTH-producing tumor-associated Cushing syndrome.
The adrenal morphology varies with the source of cortisol excess.
Slide 13 · Classifying endogenous Cushing syndrome
Endogenous cortisol excess
Measure plasma ACTH
ACTH dependent / independent
ACTH-dependent causes include pituitary tumors and ectopic ACTH secretion.
ACTH-independent causes include cortisol-producing adrenal lesions.
The classification predicts whether both glands are stimulated or ACTH is suppressed.
Slide 14 · Pituitary Cushing disease: Causal sequence
Pituitary corticotroph tumor
Excess ACTH
Bilateral adrenal hyperplasia
Excess cortisol
Sustained ACTH stimulation expands steroid-producing cortical cells.
The adrenal glands are effectors, not the autonomous source of the signal.
A corticotroph neoplasm may be small despite substantial systemic consequences.
Slide 15 · Ectopic ACTH: Endocrine effects of nonpituitary tumors
Certain neuroendocrine cancers secrete ACTH outside the pituitary.
Small-cell carcinoma of the lung is a prominent example.
Ectopic CRH secretion can also stimulate pituitary ACTH in rare settings.
High ACTH can produce bilateral adrenal cortical hyperplasia and hypercortisolism.
Slide 16 · Autonomous adrenal cortisol: Suppressed ACTH
Cortisol-secreting adrenal lesion
Elevated circulating cortisol
Feedback inhibition of ACTH
Atrophy of uninvolved cortex
An adenoma, carcinoma, or primary bilateral hyperplasia may produce ACTH-independent cortisol excess.
Both adjacent and contralateral normal cortex can atrophy in unilateral cortisol-secreting tumors.
Slide 17 · Bilateral macronodular adrenal hyperplasia
Primary bilateral macronodular hyperplasia is usually ACTH independent.
Macroscopic nodules are generally greater than 10 mm and can replace much of the cortex.
Some familial and apparently sporadic cases involve germline ARMC5 alterations.
Aberrant hormone receptors can drive cortisol secretion independently of pituitary ACTH.
Slide 18 · Pigmented micronodules and Carney complex
Micronodular cortical lesions are typically below 10 mm and may appear darkly pigmented.
Pigment corresponds to intracytoplasmic lipofuscin in compact cortical cells.
Primary pigmented nodular disease may be sporadic or part of Carney complex.
PRKAR1A pathway defects promote inappropriate cAMP-dependent signaling.
Slide 19 · Cortisol effects explain the clinical phenotype
Cortisol excess
Protein / collagen catabolism
Muscle and skin atrophy
Glucocorticoids also favor hepatic glucose production and impair peripheral glucose uptake.
The net phenotype combines fat redistribution, hypertension, hyperglycemia, and tissue fragility.
Slide 20 · Cushing syndrome: Change in body composition
Truncal obesity develops with rounded facial contours (“moon facies”).
Fat may accumulate in the posterior neck and upper back.
Muscle mass falls because glucocorticoids promote protein catabolism.
Proximal weakness reflects preferential atrophy of type II myofibers.
Slide 21 · Cushing syndrome: Skin and skeletal pathology
Collagen loss produces thin skin, easy bruising, and poor wound repair.
Abdominal striae reflect structural weakening during tissue expansion.
Bone resorption contributes to osteoporosis and fragility fractures.
Findings are mechanistically linked to prolonged glucocorticoid exposure.
Slide 22 · Cushing syndrome: Metabolic and immune effects
Hyperglycemia follows increased gluconeogenesis and reduced cellular glucose uptake.
Hypertension can be an early, nonspecific presenting feature.
Immune suppression increases susceptibility to infection.
Mood disturbance, menstrual changes, and hirsutism broaden the clinical spectrum.
Slide 23 · Cushing syndrome: Morphology by pathogenesis
Cause
Adrenal appearance
Explanation
Exogenous glucocorticoids
Bilateral cortical atrophy
Pituitary ACTH suppression
Pituitary / ectopic ACTH
Bilateral diffuse cortical hyperplasia
Sustained trophic stimulation
Primary bilateral nodular disorder
Macro- or micronodular hyperplasia
Autonomous steroidogenic signaling
Cortisol-secreting tumor
Unilateral lesion; residual cortex atrophic
Tumor cortisol suppresses ACTH
Slide 24 · Adrenal hyperplasia has recognizable patterns
Diffuse ACTH-dependent enlargement creates a broadened cortex, sometimes with subtle nodularity.
Macronodular hyperplasia contains prominent cortical nodules of variable sizes.
Micronodular hyperplasia may show dark lipofuscin-containing nodules with atrophic intervening tissue.
These patterns should not be equated simply because all can cause excess cortisol.
Slide 25 · Biochemical evidence precedes localization
A 24-hour urinary free cortisol increase supports hypercortisolism.
Loss of late-night cortisol nadir may be demonstrated with midnight salivary cortisol.
A low-dose dexamethasone suppression test may document failure to suppress.
Testing must be interpreted in clinical context before selecting adrenal or pituitary imaging.
Slide 26 · After confirming hypercortisolism: Use ACTH
Demonstrate cortisol excess
Determine plasma ACTH
Choose ACTH-dependent or -independent workup
Suppressed ACTH favors autonomous adrenal cortisol production or exogenous steroid exposure.
Nonsuppressed ACTH requires localization of pituitary versus ectopic secretion.
Suppression tests alone may be imperfect; Additional sampling may sometimes be needed.
Slide 27 · Cushing disease versus ectopic ACTH secretion
Pituitary source
Pituitary corticotroph neoplasm
ACTH-dependent cortisol excess
Bilateral adrenocortical hyperplasia
May suppress with higher-dose dexamethasone
Ectopic source
Nonpituitary ACTH-producing tumor
ACTH-dependent cortisol excess
Bilateral adrenocortical hyperplasia
Often resists high-dose dexamethasone suppression
High-dose suppression is not a definitive standalone discriminator.
Slide 28 · Hyperaldosteronism: Two fundamentally different mechanisms
Primary: Autonomous adrenal aldosterone secretion suppresses renin.
Secondary: Increased renin–angiotensin stimulation drives aldosterone release.
Both can cause sodium retention, volume expansion, and hypertension.
Distinguishing primary from secondary disease prevents erroneous etiologic classification.
Slide 29 · Renal consequences of aldosterone excess
Increased aldosterone
Na⁺ and water retention
Volume expansion / hypertension
Aldosterone stimulates mineralocorticoid receptor-mediated tubular sodium reabsorption.
Enhanced potassium excretion can produce hypokalemia.
Hypokalemia is not obligatory; Normal potassium does not exclude primary aldosteronism.
Slide 30 · Primary aldosteronism: Major source categories
Category
Defining pathologic setting
Important distinction
Bilateral idiopathic disease
Bilateral glomerulosa-type hyperplasia
Commonest source in the textbook
Aldosterone-producing adenoma
Usually solitary, small cortical adenoma
Conn syndrome
Familial forms
Inherited alterations to steroidogenesis
Multiple genetic subtypes
Adrenocortical carcinoma
Malignant autonomous production
Rare cause
Slide 31 · Conn syndrome: Aldosterone-producing adenoma
Typically a small, solitary, circumscribed bright-yellow cortical tumor.
Microscopy often resembles lipid-rich zona fasciculata rather than native glomerulosa.
ACTH secretion is usually not suppressed, so surrounding cortex is not typically atrophic.
A lesion’s size and cytology cannot independently establish its secretory status.
Slide 32 · KCNJ5 alterations: An aldosterone-producing mechanism
Mutant K⁺ channel
Loss of ion selectivity / depolarization
Ca²⁺-linked aldosterone synthase activation
Recurrent somatic KCNJ5 mutations in aldosterone-producing adenomas.
The effect is sustained aldosterone biosynthesis rather than simple trophic proliferation.
Slide 33 · Familial hyperaldosteronism type I
CYP11B1-responsive promoter
Chimeric CYP11B1–CYP11B2 regulation
ACTH-driven aldosterone synthase
Glucocorticoid-remediable aldosteronism links aldosterone synthesis to pituitary ACTH.
Promoter rearrangement—not cortical destruction—creates aberrant hormone regulation.
Slide 34 · Primary and secondary hyperaldosteronism
Primary: Adrenal autonomy
Aldosterone elevated
Renin suppressed
Adrenal adenoma or bilateral hyperplasia
Hypertension; K⁺ may be normal
Secondary: Renin-angiotensin drive
Aldosterone elevated
Renin elevated / activated
Renal hypoperfusion, edema states, or related stimuli
Correction of underlying driver is central
Slide 35 · Morphology: Bilateral glomerulosa hyperplasia
The cortex may show subtle bilateral enlargement rather than a dominant mass.
Glomerulosa-like cells expand in diffuse and focal patterns.
Wedge-shaped hyperplastic foci may extend inward from the gland periphery.
The microscopic differential includes a discrete aldosterone-producing adenoma.
Slide 36 · Hyperaldosteronism: Cardiovascular consequences
Persistent aldosterone-mediated volume expansion elevates blood pressure.
The textbook links the syndrome with cardiac hypertrophy and cardiovascular events.
Renal potassium wasting can cause weakness, paresthesias, or arrhythmic risk.
Severity of hypertension and potassium concentration alone do not reliably identify the cause.
Slide 37 · Evaluating suspected primary hyperaldosteronism
Clinical suspicion
Aldosterone : Renin assessment
Confirm autonomous secretion
Elevated aldosterone relative to suppressed renin is a central biochemical clue.
Positive screening generally requires appropriate confirmation and subtype evaluation.
Preanalytic, physiologic, and medication-related confounding can influence testing.
Slide 38 · The adrenal cortex is a source of androgen precursors
Zona reticularis generates dehydroepiandrosterone and androstenedione.
Peripheral conversion contributes biologically active androgens.
ACTH regulates adrenal androgen output.
Marked virilization may indicate congenital steroidogenic defects or an androgen-producing neoplasm.
Slide 39 · Androgen-secreting neoplasms: Interpret the phenotype
Adrenocortical tumors can produce virilization, occasionally with cortisol excess.
A virilizing adrenal neoplasm is more likely to be carcinoma than adenoma.
Hormone production must be established biochemically, not deduced from appearance alone.
Morphology is evaluated separately for evidence of malignant growth.
Slide 40 · Congenital adrenal hyperplasia: Feedback mechanism
Steroidogenic enzyme deficiency
Reduced cortisol feedback
Raised ACTH and bilateral hyperplasia
Excess androgen pathway flux
CAH encompasses inherited steroid biosynthetic disorders.
Mineralocorticoid deficiency occurs in some, not all, enzyme defects.
The clinical outcome depends on residual enzyme activity and affected pathways.
Slide 41 · 21-hydroxylase deficiency: Two blocked outputs
CYP21A2-associated enzyme defect
Reduced cortisol ± aldosterone
ACTH elevation and androgen excess
21-hydroxylase is required in the glucocorticoid and mineralocorticoid pathways.
Residual activity determines whether salt wasting accompanies virilization.
This as the predominant genetic cause of CAH.
Slide 42 · 21-hydroxylase deficiency: Clinical phenotypes
Phenotype
Cortisol / aldosterone effect
Typical presentation
Classic salt-wasting
Marked deficiency of both hormones
Neonatal dehydration, hypotension, hyperkalemia
Classic simple-virilizing
Cortisol deficient; mineralocorticoid function sufficient
Genital virilization without salt crisis
Nonclassic
Partial enzyme deficiency
Later hirsutism, acne, menstrual changes
Slide 43 · Salt-wasting CAH is a neonatal emergency
Severe mineralocorticoid deficiency produces sodium loss and hyperkalemia.
Volume depletion can progress to hypotension, acidosis, and circulatory collapse.
Affected newborns may appear stable initially because placental and maternal physiology maintained fluid balance.
Cortisol insufficiency and androgen excess coexist.
Slide 44 · Simple-virilizing CAH: Cortisol feedback failure
Residual mineralocorticoid synthesis prevents the classic salt-wasting crisis.
Deficient cortisol feedback sustains excess ACTH secretion.
Androgen overproduction can produce genital virilization or precocious pubertal changes.
Absence of salt wasting does not mean the cortisol axis is normal.
Slide 45 · Nonclassic CAH: Partial steroidogenic impairment
A partial 21-hydroxylase deficiency may present beyond infancy.
Hirsutism, acne, oligomenorrhea, and menstrual irregularities are typical clues.
Presentation overlaps with common alternative causes of hyperandrogenism.
The diagnosis requires evaluation of steroid biosynthesis rather than appearance alone.
Slide 46 · CAH morphology follows chronic ACTH stimulation
Both adrenal glands may be markedly enlarged and nodular.
A lipid-depleted, brown expanded cortex is described in severe disease.
Compact eosinophilic cells mingle with lipid-containing cortical cells.
Anterior pituitary corticotroph hyperplasia can accompany chronic low cortisol feedback.
Slide 47 · Why glucocorticoid replacement reduces virilization
Replace deficient glucocorticoid
Restore pituitary feedback
Lower ACTH
Lower adrenal androgen drive
Replacement treats cortisol deficiency and limits inappropriate ACTH-mediated stimulation.
Salt-wasting forms also require mineralocorticoid replacement.
The therapeutic logic directly follows the endocrine feedback defect.
Slide 48 · Adrenocortical insufficiency: Classify by level
Primary insufficiency arises from cortical loss or failure of steroid biosynthesis.
Secondary insufficiency reflects inadequate pituitary ACTH output.
Primary disease can present acutely as a crisis or chronically as Addison disease.
Aldosterone preservation in secondary disease has important diagnostic implications.
Slide 49 · Acute adrenal crisis: Stress exceeds reserve
Reduced cortical reserve
Severe physiologic stress
Inadequate cortisol response
Circulatory deterioration
Acute decompensation may complicate established chronic adrenal insufficiency.
Rapid steroid withdrawal can precipitate crisis in ACTH-suppressed patients.
Bilateral hemorrhagic destruction is another potentially catastrophic mechanism.
Slide 50 · Primary acute insufficiency: Common precipitating settings
Unrecognized chronic cortisol deficiency stressed by infection or illness.
Abrupt discontinuation of long-term exogenous glucocorticoids.
Bilateral adrenal hemorrhage, including DIC-associated injury or severe infection.
Immune-checkpoint therapy may injure adrenal or pituitary tissue.
Slide 51 · Waterhouse–Friderichsen syndrome
A fulminant infection classically associated with meningococcal septicemia.
Rapid shock and DIC accompany extensive purpura.
Massive bilateral adrenal hemorrhage destroys steroidogenic reserve.
It is a clinicopathologic emergency; Delayed recognition may be fatal.
Slide 52 · Waterhouse–Friderichsen: Tissue injury sequence
Septicemia / endothelial injury
DIC and adrenal hemorrhage
Loss of viable cortex
Acute adrenal failure
Hemorrhage can begin near the medullary venous sinusoids and extend into the cortex.
Gross glands may be largely replaced by clotted blood with little preserved architecture.
Slide 53 · Addison disease: Progressive primary cortical loss
Chronic adrenal insufficiency follows progressive destruction of the cortex.
Substantial functional tissue may be lost before the clinical syndrome becomes evident.
Etiologies include autoimmunity, infection, infiltration, hemorrhage, and metastatic disease.
Primary hormone deficits produce high compensatory ACTH and may affect aldosterone.
Slide 54 · Autoimmune adrenalitis: Loss of steroidogenic cells
Immune-mediated cortical damage
Reduced steroid synthesis
Increased pituitary ACTH
Hyperpigmentation / insufficiency
Antibodies to steroidogenic enzymes, including 21-hydroxylase, may support an autoimmune process.
Autoimmune adrenalitis can be isolated or accompany polyendocrine autoimmunity.
Slide 55 · APS-1 links adrenal autoimmunity to central tolerance
The syndrome is associated with defects in the AIRE gene.
Defective thymic expression of tissue antigens impairs deletion of autoreactive T cells.
Adrenalitis can coexist with hypoparathyroidism and mucocutaneous candidiasis.
The source explains candidiasis by impaired Th17-related antifungal immunity.
Slide 56 · Autoimmune polyendocrine syndromes
APS-1
AIRE-related central tolerance defect
Adrenalitis and hypoparathyroidism may occur
Chronic mucocutaneous candidiasis
Ectodermal abnormalities can be present
APS-2
Adrenalitis with autoimmune thyroid disease
Type 1 diabetes may coexist
More frequent than APS-1
No defining candidiasis or ectodermal dysplasia
Slide 57 · Other causes of primary chronic adrenal loss
Tuberculosis and fungal infection may destroy both glands.
Opportunistic infections are especially relevant in immunocompromised patients.
Metastatic carcinoma can extensively replace adrenal parenchyma.
Amyloid, granulomatous disease, iron deposition, and inherited disorders form additional mechanisms.
Slide 58 · Primary Addison disease: Phenotype from hormone loss
Weakness, fatigue, gastrointestinal disturbance, and hypotension are common.
ACTH elevation produces hyperpigmentation in primary disease.
Mineralocorticoid deficiency can contribute to salt loss and hyperkalemia.
Clinical severity depends on the extent and tempo of cortical destruction.
Slide 59 · Secondary adrenal insufficiency: Inadequate ACTH
Pituitary or hypothalamic injury reduces ACTH drive to the cortex.
Long-term exogenous glucocorticoids can suppress endogenous ACTH.
Cortisol and adrenal androgen output fall, but aldosterone is usually preserved.
The absence of hyperpigmentation and marked hyperkalemia helps distinguish secondary disease.
Slide 60 · Primary versus secondary adrenal insufficiency
Feature
Primary cortical failure
Secondary ACTH deficiency
ACTH
High (loss of cortisol feedback)
Low or inappropriately normal
Cortisol
Reduced
Reduced
Aldosterone
Often reduced
Usually normal / near normal
Hyperpigmentation
May be present
Not characteristic
Hyperkalemia
May occur
Not characteristic
Slide 61 · Cosyntropin response tests cortical reserve
Administer synthetic ACTH
Measure cortisol response
Interpret adrenal reserve and context
Primary cortical destruction reduces cortisol responsiveness.
Long-standing secondary ACTH deficiency can also blunt the response through adrenal atrophy.
Recent-onset secondary deficiency may retain an initially normal response.
Slide 62 · Morphology of secondary insufficiency
Loss of sustained ACTH stimulation shrinks cortisol-producing cortical compartments.
The gland can be small and flattened while retaining yellow cortical tissue.
Zona glomerulosa is relatively preserved because aldosterone does not depend primarily on ACTH.
A normal-size gland does not exclude recent-onset secondary dysfunction.
Slide 63 · Adrenocortical neoplasms: A functional spectrum
Many cortical adenomas are nonfunctional and incidentally detected.
Functioning lesions may cause cortisol or aldosterone excess.
Pronounced virilization raises concern for adrenocortical carcinoma.
A diagnosis of functionality requires clinical and biochemical evidence.
Slide 64 · Adrenocortical adenoma: Core morphologic features
A circumscribed yellow to yellow-brown nodule often resembles normal steroidogenic cortex.
Lipid-rich cells can have pale, vacuolated cytoplasm.
Limited nuclear pleomorphism can be present without establishing malignancy.
Mitotic activity is generally low; Hormone function is not determined by H&E appearance.
Slide 65 · Carcinoma: Destructive growth changes the diagnosis
Adrenocortical carcinoma is often a large, infiltrative tumor effacing the gland.
Cut surfaces may be variegated with hemorrhage, necrosis, and cystic change.
Venous, lymphatic, and distant invasion are important malignant behaviors.
Smaller or better-differentiated carcinomas may be morphologically challenging.
Slide 66 · Cortical adenoma versus carcinoma: Overview
Criterion
Adenoma (typical)
Carcinoma (typical)
Gross border
Well circumscribed
Often infiltrative / poorly demarcated
Gross cut surface
Yellow, lipid rich
Variegated necrosis or hemorrhage
Cytologic variability
Mild atypia possible
May be markedly atypical or deceptively bland
Biologic behavior
Noninvasive
Can invade veins and metastasize
Slide 67 · Carcinoma genetics: Separate susceptibility from diagnosis
Li–Fraumeni syndrome predisposes to carcinoma through germline TP53 alterations.
Beckwith–Wiedemann syndrome links adrenal tumor susceptibility to IGF2 imprinting biology.
Somatic TP53 changes and elevated IGF2 expression may also occur in sporadic tumors.
Genetic associations are not substitutes for integrated morphologic and clinical assessment.
Slide 68 · Cortical lineage versus adrenal metastasis
Metastases to the adrenal are more frequent than primary adrenocortical carcinomas.
Cortical tumors may express steroidogenic factor 1 (SF-1) and inhibin-α.
Immunohistochemical results should be interpreted within a differential, not in isolation.
Clinical imaging and evidence of an extra-adrenal primary are crucial for classification.
Slide 69 · Adrenal incidentaloma is a clinical discovery pattern
Imaging performed for unrelated complaints can reveal a silent adrenal mass.
Many incidental lesions are small, nonsecretory cortical adenomas.
A subset produces cortisol without overt classic Cushing features: Mild autonomous cortisol secretion.
Risk appraisal combines hormone evaluation with radiologic and pathologic assessment.
Slide 70 · Adrenal myelolipoma and cysts: Relevant mimics
Myelolipoma is a benign admixture of mature adipose and hematopoietic tissue.
Some myelolipomas become large but are frequently incidentally discovered.
Cysts and cystic tumor degeneration can present as apparently nonfunctional masses.
Not all adrenal masses are steroid-producing cortical neoplasms.
Slide 71 · An integrated adrenal pathology checklist
Question
Interpretation
Next intellectual step
What is produced?
Cortisol, aldosterone, androgen, or none
Document biochemical functionality
What drives production?
ACTH, renin–angiotensin, or autonomous lesion
Interpret endocrine feedback
What is the tissue response?
Atrophy, diffuse/nodular hyperplasia, mass
Describe native morphology
Is it malignant?
Invasion and integrated tumor features
Evaluate carcinoma versus metastasis
Slide 72 · Case integration: Hypertension and low renin
Hypertension ± hypokalemia
Elevated aldosterone relative to renin
Consider primary aldosteronism
An adenoma and bilateral glomerulosa hyperplasia are different pathologic subtypes.
Normal potassium does not exclude the syndrome.
Biochemical subtype localization must precede causal attribution to an imaging nodule.
Slide 73 · Case integration: Cortisol excess with low ACTH
Cushing phenotype and hypercortisolism
Low ACTH
Investigate exogenous or adrenal source
A cortisol-producing adrenal neoplasm may suppress the contralateral cortex.
By contrast, exogenous glucocorticoids may produce bilateral ACTH-dependent atrophy.
A mass is not automatically the cause without biochemical correlation.
Slide 74 · Case integration: Shock and adrenal hemorrhage
Sepsis with purpura and DIC
Bilateral adrenal hemorrhage
Acute cortical destruction / crisis
Waterhouse–Friderichsen syndrome is an urgent clinical-pathologic diagnosis.
Massive hemorrhage can obliterate the usual adrenal architecture.
Its mechanism is not the chronic autoimmune destruction of Addison disease.
Slide 75 · Integrated principles of adrenal cortical pathology
Zone-specific steroid production predicts the functional syndrome.
Pituitary ACTH explains both hyperplasia during stimulation and atrophy during suppression.
Primary versus secondary failure differs in ACTH, aldosterone, and pigmentation patterns.
Adrenal neoplasm classification requires morphology plus hormonal and clinical evidence.
Slide 76 · Primary reference and scope
Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition (2026).
Chapter 24, The Endocrine System: Adrenal glands and adrenal cortex, printed pp. 1012–1023.
Source excerpt transcribed in the project’s robbins.md file; diagrams here are original editable teaching schematics.
Original textbook photomicrographs were not reproduced because source image files and reuse rights were unavailable.